Sarah Adams, MD, hopes her new ovarian cancer clinical trial will help to save women's lives. The new trial recently launched at the UNM Comprehensive Cancer Center. The trial uses a PARP inhibitor to kill ovarian cancer cells and an antibody to boost the immune system's response to the cells. The immune therapy could help to prevent recurrence (read more about the clinical trial to learn more).
Dr. Adams talks to Erica Zucco, KOB-TV, about the trial:
Dr. Adams also talked to Ellen Berkovitch at KSFR-FM and to Mike Jaxson at KSVP-AM:
The trial is open to women with ovarian cancer who do not have an autoimmune condition that may worsen with the antibody treatment. Women with ovarian cancer should talk to their doctor or call the UNM Cancer Center for more information about the trial and to see if they qualify.
Tags: UNM CC In the News